Uppsala Monitoring Centre
Paulina Nakielny is a seasoned professional with extensive experience in project and product management, currently serving as a Product Manager at Uppsala Monitoring Centre since June 2020. Previously, Paulina was a Project Manager at Klarna from June 2017 to May 2020, leading market launches and cross-functional teams, and also held the role of Executive Assistant/Chief of Staff to the CAO, facilitating communication and organizational processes. Paulina's earlier experience includes positions as a Project Coordinator at the European Centre for Disease Prevention and Control, where financial processes and international project coordination were key responsibilities, and as an Assistant to Project Manager at EuroHealthNet. Additionally, Paulina participated in a mentorship program through AmCham Sweden focused on leadership development. Academic qualifications include a Master's degree in International Economics from Krakow University of Economics and Bachelor's degrees in International Relations and American Studies from Krakow University of Economics and Jagiellonian University, respectively.
This person is not in any teams
Uppsala Monitoring Centre
Uppsala Monitoring Centre is an independent, non-profit foundation and a centre for international service and scientific research in the field of pharmacovigilance. We advance the safety of patients by exploring and understanding the risks and benefits of medicines, with the ultimate aim of helping patients and physicians make wise therapeutic decisions. For more than 40 years, we have provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring, expanding the global pharmacovigilance network to reach more than 95% of the world’s population. We create partnerships that bring together resources, expertise, and a shared vision of patient safety. Today, we continue to build a global drug safety culture by supporting and engaging all pharmacovigilance stakeholders, from national centres to regulators, academia and the pharma industry.